Latest News

Biopharma Updates: New Leadership, Drug Trials, and IPOs Shape Industry Landscape

Frank Dolan May 10, 2025

Eli Lilly’s $250M Partnership with Purdue University & More: Key Updates in Pharma and Biotech

Frank Dolan May 10, 2025

Iovance Biotherapeutics Stock Plummets 44%: What Investors Need to Know About 2025 Projections

Frank Dolan May 9, 2025

Insilico Medicine’s Third Attempt at an IPO: Aiming Big in Hong Kong’s Booming Biotech Market

Frank Dolan May 9, 2025

Biotech Sector Faces Major Workforce Cuts: Layoffs Surge as Firms Navigate Market Turbulence

Frank Dolan May 9, 2025

Insitro Cuts Workforce by 22% Amidst Biotech Industry Challenges: What It Means for the Future of AI in Medicine

Frank Dolan May 8, 2025

Critical FDA Meeting: Shaping the Future of COVID-19 Vaccines for Fall and Winter 2023

Frank Dolan May 8, 2025

FDA to Discuss COVID-19 Vaccine Boosters on May 22, 2025: What to Expect from Stricter Approvals and New Leadership

Frank Dolan May 8, 2025

Avadel Pharmaceuticals Poised to Expand Lumryz Label After Court Victory

Frank Dolan May 7, 2025

Marea Therapeutics Advances to Phase 2b: Promising Results from New Biomarker Data for Cardiovascular Drug

Frank Dolan May 7, 2025

Vinay Prasad’s FDA Leadership: A Turning Point for Cell and Gene Therapy Stocks?

Frank Dolan May 7, 2025

Revolutionizing US Drug Pricing: Bipartisan Efforts to Align with Global Rates Gain Momentum

Frank Dolan May 6, 2025

Singapore Biotech Secures $45M for Groundbreaking Gene Therapy in Heart Disorders: Eyes European Market Expansion

Frank Dolan May 6, 2025

PTC Stock Dips as New Huntington’s Drug Data Raises Questions on Efficacy

Frank Dolan May 6, 2025

BioNTech Assures Investors: RFK Jr.’s Vaccine Proposal Has No Immediate Threat to COVID-19 Franchise

Frank Dolan May 5, 2025

Promising Breakthroughs: First Human Data on In Vivo CAR-T Therapy from China Biotech Trials

Frank Dolan May 5, 2025

Biopharma Earnings Season: Key Developments, FDA Delays, and Market Insights

Frank Dolan May 3, 2025

Amgen’s Biosimilar Surge: $150 Million in Stelara Sales and a 35% Revenue Boost in Q1 2025

Frank Dolan May 3, 2025

White House Budget Proposal: Major Cuts to NIH and CDC Signals Shift in Public Health Funding

Frank Dolan May 2, 2025

HHS Launches $500 Million Universal Vaccine Initiative to Combat Future Pandemics

Frank Dolan May 2, 2025

Stay up to date on the latest news

By pressing the Subscribe button, you confirm that you have read our Privacy Policy.

Biopharma Updates: New Leadership, Drug Trials, and IPOs Shape Industry Landscape

Eli Lilly’s $250M Partnership with Purdue University & More: Key Updates in Pharma and Biotech

Iovance Biotherapeutics Stock Plummets 44%: What Investors Need to Know About 2025 Projections

Email Us

info at arsenal-advisors.com

Headquarters

Cambridge, MA USA

Latest News

Biopharma Updates: New Leadership, Drug Trials, and IPOs Shape Industry Landscape

Eli Lilly’s $250M Partnership with Purdue University & More: Key Updates in Pharma and Biotech

Iovance Biotherapeutics Stock Plummets 44%: What Investors Need to Know About 2025 Projections

Insilico Medicine’s Third Attempt at an IPO: Aiming Big in Hong Kong’s Booming Biotech Market

Biotech Sector Faces Major Workforce Cuts: Layoffs Surge as Firms Navigate Market Turbulence

Insitro Cuts Workforce by 22% Amidst Biotech Industry Challenges: What It Means for the Future of AI in Medicine

Critical FDA Meeting: Shaping the Future of COVID-19 Vaccines for Fall and Winter 2023

FDA to Discuss COVID-19 Vaccine Boosters on May 22, 2025: What to Expect from Stricter Approvals and New Leadership

Avadel Pharmaceuticals Poised to Expand Lumryz Label After Court Victory

Marea Therapeutics Advances to Phase 2b: Promising Results from New Biomarker Data for Cardiovascular Drug

Vinay Prasad’s FDA Leadership: A Turning Point for Cell and Gene Therapy Stocks?

Revolutionizing US Drug Pricing: Bipartisan Efforts to Align with Global Rates Gain Momentum

Singapore Biotech Secures $45M for Groundbreaking Gene Therapy in Heart Disorders: Eyes European Market Expansion

PTC Stock Dips as New Huntington’s Drug Data Raises Questions on Efficacy

BioNTech Assures Investors: RFK Jr.’s Vaccine Proposal Has No Immediate Threat to COVID-19 Franchise

Promising Breakthroughs: First Human Data on In Vivo CAR-T Therapy from China Biotech Trials

Biopharma Earnings Season: Key Developments, FDA Delays, and Market Insights

Amgen’s Biosimilar Surge: $150 Million in Stelara Sales and a 35% Revenue Boost in Q1 2025

White House Budget Proposal: Major Cuts to NIH and CDC Signals Shift in Public Health Funding

HHS Launches $500 Million Universal Vaccine Initiative to Combat Future Pandemics

Stay up to date on the latest news

Access the Ideas that Accelerate Innovation

Trending News

Biopharma Updates: New Leadership, Drug Trials, and IPOs Shape Industry Landscape

Eli Lilly’s $250M Partnership with Purdue University & More: Key Updates in Pharma and Biotech

Iovance Biotherapeutics Stock Plummets 44%: What Investors Need to Know About 2025 Projections

Popular Categories

Information

Contact Us